Lansoprazol "doc"

Lansoprazole, the active ingredient in Lansoprazol "doc", is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to manage conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Lansoprazol "doc" as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies, clinics and other health‑care institutions worldwide, ensuring consistent quality and regulatory compliance. The company handles export logistics, documentation and post‑delivery support for global partners.

Lansoprazole is indicated for several acid‑related gastrointestinal conditions where suppression of gastric secretion is required.

- Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, often transient. - Nausea: occasional stomach discomfort. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, anaphylaxis. - Clostridioides difficile infection: severe colitis. - Low magnesium levels: muscle cramps, arrhythmia. - Vitamin B12 deficiency: anemia, neuropathy. - Elevated liver enzymes: hepatitis signs. - Acute pancreatitis: abdominal pain radiating to back.

Before initiating therapy, consider the following precautions.

- Assess renal function: adjust use in severe renal impairment. - Monitor for drug interactions: especially with clopidogrel, warfarin, methotrexate. - Use caution in elderly: higher risk of bone fractures. - Avoid prolonged use without supervision: risk of nutrient deficiencies. - Store at ambient temperature: keep in original container, protect from moisture and light.

Lansoprazole may interact with several medicines; categorize them as follows.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of atazanavir. - Methotrexate: increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: variable INR changes. - Digoxin: reduced serum levels. - Ciclosporin: increased blood concentrations.